The study included
223 patients, with 115 (54.5%) developing AKI in the first seven days
postoperatively. This group was predominantly
male
(70.9%), with an average age of 53.46 (SD=±12.8 years) and a mean MELD score of
28.87 (SD=±6.1). The average body mass index (BMI) was 26.26 (SD=±21.5). The
main indications for LT were Hepatitis C (29.6%) and Alcoholic Liver Disease
(23.8%). Among these patients, 55.2% had hepatocellular carcinoma, 36.4% had
hypertension (HTN), 28% had diabetes (DM), and 5.6% had dyslipidemia. In predictive factor
analysis, 50% of female patients experienced AKI, compared to 56.3% in males (p=0,408).
In univariate analysis were associated with AKI dyslipidemia (83.3% vs. 16,7%
in non-AKI; p
< 0.04), HCC (47,4% vs 52,6% in non-AKI, p<0,06),
HTN (50,6% vs 49,9%,p<0,4)
and DM (63,9% vs 36,1%,p<0,08).
Concerning blood transfusion, 77.8% of those receiving 3 to 5 units and 75% of
those receiving more than 5 units developed AKI (p<0,01).
Early complications increased the percentage of patients with the studied
clinical outcome to 68.8% (p<0,001).
Another variable analyzed was the use of vasopressor drugs, with 60.8% of
patients using them developing AKI (p<0,01).
In
multivariate analysis age (54,19±11,4 vs
53,49±13,7, p<0,7),
BMI (1,817±0,8 vs. 1,759±0,9,p<0,7)
and
MELD (21,67±5,7 vs. 20,06±6,5, p<0,11)
were
associated
with
AKI.